New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses

Por Alice Gutjahr, Laura Papagno, Fabienne Vernejoul, Thierry Lioux, Fabienne Jospin, Blandine Chanut, Eric Perouzel, Nicolas Rochereau, Victor Appay, Bernard Verrier, Stéphane Paul
Publicado em 2020-08-01